Territory Account Manager
About the job
- A four-year degree and at least five years of related sales or clinical experience, or a two-year degree and at least seven years of related sales or clinical experience.
- Proven sales skills and a track record of sales achievement.
- Experience building and supporting strong clinical programs is preferred.
- Ability to quickly learn clinical and technical information and communicate it to customers.
- Ability to develop relationships with administrative staff, cardiologists, referring physician practices, hospital marketing teams, and other strategic stakeholders to drive awareness of the cCTA/FFRct pathway, broaden referrals, and deepen adoption.
- Ability to coordinate field and headquarters resources to support customers and execute program development plans, sales, marketing, education, and training.
- Ability to explain medical technologies to referring physicians and health care professionals.
- Ability to initiate, organize, and complete projects independently.
- Ability to solve problems, especially under pressure.
- Ability to work effectively with customers from a wide range of technical and clinical backgrounds.
- Strong verbal and written communication skills and professional etiquette.
- Experience with Salesforce.com or a similar customer relationship management system.
- A degree in Science, Medical, Business, Marketing, or a Technical field is preferred.
- Prior experience in medical devices, cardiology pharmaceuticals, cardiology radiopharmaceuticals, hospitals, or medical software is highly desired.
- Experience introducing new cardiovascular technologies into hospitals is highly desired.
- Work with key strategic accounts to drive growth and adoption of a cCTA and FFRct clinical pathway, developing and executing business development plans with account stakeholders.
- Facilitate cross-functional collaboration, coordinating internal leadership and physician mentors, dinner programs, VIP visits, CT pathway roadshows, and referring physician office meetings with Territory Sales, Marketing, Market Access, CT Applications, Product Development, and Clinical teams.
- Maintain and build relationships with referring physicians and other key clinical stakeholders.
- Educate customers on Heartflow’s value proposition through presentations and discussions with referring physicians.
- Promote and champion Heartflow, building advocacy.
- Meet or exceed quota for strategic accounts within existing customer locations.
- Increase cCTA growth through conversion of non-invasive tests and increase FFRct penetration and case growth over baseline in assigned accounts.
- Knowledge of cardiac patient pathways and diagnostic technology.
About the company
HeartFlow provides a non-invasive cardiac test that helps doctors visualize a patient’s coronary arteries to diagnose and plan treatment for heart disease. It uses a proprietary set of analyses—FFRCT Analysis, RoadMap Analysis, Plaque Analysis, and HeartFlow Planner—to create a detailed, patient-specific visualization from imaging data, enabling clinicians to assess blood flow and plaque without surgery. This approach reduces the need for invasive procedures, lowers risk for patients, and can cut costs for healthcare providers. Compared with traditional methods, HeartFlow offers validated, FDA-cleared tools that integrate multiple analyses into one platform, giving physicians a clearer, data-driven basis for diagnosis and treatment decisions. The company’s goal is to improve cardiovascular care by making safer, more efficient diagnosis and treatment planning widely available in hospitals and clinics around the world.
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2010
Get referred to HeartFlow
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 48% to $64.1 million, lifting full-year guidance.
- Plaque revenue reached $7.8 million in Q2 2026, becoming a second growth engine.
- Gross margin hit 83%, showing strong operating leverage and software economics.
What critics are saying
- Cleerly’s July 2026 plaque clearance and FFR-CT code pressure HeartFlow pricing power.
- The April 2026 Texas patent suit against Cleerly drains management time and cash.
- Growth depends on reimbursement and clinician adoption; any payer pullback hits 2027 revenue fast.
What makes HeartFlow unique
- HeartFlow One unifies FFRCT, Plaque Analysis, and PCI Navigator in one workflow.
- July 2026 Plaque Staging uses total plaque volume with up to 16 years follow-up.
- HeartFlow holds the only FDA-cleared AI plaque tool with reported 95% IVUS agreement.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Stock Options
- 401(k) Company Match